1-Jahres-Chart (nicht börsennotiert)
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CORNERSTONE THERAPEUTICS Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 94,18 | -0,18 % | Cognizant Expands Partnership With Gilead Sciences To Enhance Efficiency And AI Integration | TEANECK (dpa-AFX) - Cognizant (CTSH) Thursday announced that it has expanded its long-standing collaboration with Gilead Sciences (GILD) to enhance cost efficiency and productivity. The partnership... ► Artikel lesen | |
| ZOETIS | 164,92 | -0,55 % | Zoetis updates Librela label after post-approval data | ||
| INCYTE | 71,56 | +0,28 % | Incyte Gears Up to Report Q4 Earnings: Here's What You Should Know | ||
| AMARIN | 0,540 | +0,93 % | Amarin Corporation plc: Amarin Appoints Peter Fishman Chief Financial Officer | DUBLIN and BRIDGEWATER, N.J., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Peter Fishman has been appointed as Chief Financial Officer for the Company... ► Artikel lesen | |
| CASSAVA SCIENCES | 2,263 | -1,86 % | Looking Into Cassava Sciences' Recent Short Interest | ||
| LIGAND PHARMACEUTICALS | 110,00 | -3,51 % | ROUNDUP: Ligand Pharmaceuticals Boosts FY24 Outlook | WASHINGTON (dpa-AFX) - While reporting financial results for the third quarter on Thursday, biopharmaceutical company Ligand Pharmaceuticals, Inc. (LGND) raised its core adjusted earnings and... ► Artikel lesen | |
| ACHIEVE LIFE SCIENCES | 3,205 | +0,63 % | Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission | Over 300 Participants Have Completed Cumulative Six Months of Cytisinicline Treatment in the ORCA-OL Trial, Completing the Long-Term Exposure Requirement for NDA Submission ORCA-OL Long-Term Exposure... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 313,20 | +0,71 % | AKTIONÄR-Hot-Stock Madrigal: Erneute Übernahmegerüchte - Aktie mit Kurssprung | Am späten Freitagabend hat die Aktie des Biotech-Unternehmens Madrigal einen starken Kursanstieg verzeichnet. Erneut halten sich Gerüchte um die Gesellschaft, die mit Rezdiffra (Resmetirom) die erste... ► Artikel lesen | |
| SEELOS THERAPEUTICS | 2,000 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.10.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 24.10.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.10.2024ISIN NameAU0000114977 BOOKTOPIA... ► Artikel lesen | |
| ENZON PHARMACEUTICALS | 0,107 | 0,00 % | ENZON PHARMACEUTICALS, INC. - 8-K, Current Report | ||
| TALPHERA | 0,599 | -0,66 % | Talphera, Inc.: Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study | Submission of a Prior Approval Supplement for a reduction in the number of patients in the NEPHRO CRRT study is expected within the coming week
The FDA agreed to... ► Artikel lesen | |
| RIGEL PHARMACEUTICALS | 21,200 | +4,95 % | Rigel Pharmaceuticals Reports Preliminary Q4 Results; Issues 2025 Outlook | WASHINGTON (dpa-AFX) - Rigel Pharmaceuticals, Inc. (RIGL) said it expects to report fourth quarter total revenue of $57.6 million, compared to $35.8 million for the same period of 2023. Rigel... ► Artikel lesen | |
| ANI PHARMACEUTICALS | 56,50 | 0,00 % | ANI Pharma Expects FY24 Adj. EPS, Total Net Revenues To Meet Or Exceed Outlook | WASHINGTON (dpa-AFX) - ANI Pharmaceuticals, Inc. (ANIP), Monday stated that it expects total net revenues, and adjusted earnings per share to be at or above the company's financial outlook for... ► Artikel lesen | |
| SAVARA | 2,720 | 0,00 % | SVRA stock touches 52-week low at $2.6 amid market challenges | ||
| MOLECULAR TEMPLATES | 0,107 | -0,56 % | Molecular Templates, Inc.: Molecular Templates Announces Notice of Delisting and Failure to Satisfy Continued Listing Rules | AUSTIN, Texas, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, "Molecular Templates," or "MTEM" or the "Company"), a clinical-stage biopharmaceutical company focused on... ► Artikel lesen |
Das Unternehmen CORNERSTONE THERAPEUTICS INC kann der Branche Pharma zugeordnet werden.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CORNERSTONE THERAPEUTICS INC finden Sie auf Wallstreet Online.
